Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- Registration Number
- NCT00000230
- Lead Sponsor
- University of Vermont
- Brief Summary
The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with naltrexone.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall treatment outcome Drug use Retention Weeks continuous abstinence Weeks abstinent
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Treatment Research Center
🇺🇸Burlington, Vermont, United States
Treatment Research Center🇺🇸Burlington, Vermont, United States